Engineering the blood–brain barrier on chip: advances in preclinical drug penetration and disease modeling
Advanced Drug Delivery Reviews · 2026-07 · 234 · 115881
DOI: 10.1016/j.addr.2026.115881 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2026-07. Verfasst von Cheick Sissoko und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, University of Cincinnati, Cincinnati, OH 45221, USA; Center for Stem Cell and Organoid Medicine, Cincinnati Chi…. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Drug Delivery Systems, Lab-On-A-Chip Devices. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 208 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: International Foundation for Ethical Research, University of Cincinnati.
Abstract (Originalsprache)
The blood-brain barrier (BBB) remains the single most significant obstacle to the successful delivery of therapeutics to the central nervous system (CNS), with over 98% of small-molecule drugs failing to penetrate the brain parenchyma. Conventional preclinical models ranging from static Transwell® assays to healthy animal surrogates, frequently fail to predict human pharmacokinetic profiles due to species-specific differences and a lack of physiological complexity. This review examines the emergence of BBB-on-chip technologies as a transformative solution to bridge this translational gap. We detail the bioengineering strategies enabling the reconstitution of the human neurovascular unit in vitro, including the integration of induced pluripotent stem cell (iPSC)-derived cellular components, physiological shear stress, and 3D extracellular matrices. We critically evaluate the application of these microphysiological systems (MPS) in assessing diverse therapeutic modalities, from small molecules and antibodies exploiting receptor-mediated transcytosis to complex nanocarriers. Furthermore, we highlight a paradigm shift in preclinical testing: moving beyond healthy baselines to model pathological BBB phenotypes associated with neurodegenerative diseases, brain tumors, and acute injuries. By capturing disease-specific defects such as barrier leakage and transporter dysregulation, these "disease-tuned" platforms offer unprecedented mechanistic insight into drug delivery under compromised conditions. Finally, we discuss current translational hurdles, including material limitations and validation standards, and propose a future development where high-fidelity in vitro data are integrated with physiologically based pharmacokinetic (PBPK) modeling to enable robust in silico-in vitro extrapolation (IVIVE) for clinical prediction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Engineering, University of Cincinnati, Cincinnati, OH 45221, USA; Center for Stem Cell and Organoid Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45221, USA.
- TU Wien, Faculty of Technical Chemistry, Getreidemarkt 9, 1060 Vienna, Austria.
- Departments of Mechanical Engineering and Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
- Department of Biomedical Engineering, University of Cincinnati, Cincinnati, OH 45221, USA; Center for Stem Cell and Organoid Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45221, USA. Electronic…
Förderung
- International Foundation for Ethical Research
- University of Cincinnati
Zitieren
APA
Sissoko, C., Spitz, S., Zhang, Z., Abedi, K., Kamm, R. D., & Barrile, R. (2026). Engineering the blood–brain barrier on chip: advances in preclinical drug penetration and disease modeling. Advanced Drug Delivery Reviews, 234, 115881. https://doi.org/10.1016/j.addr.2026.115881
Vancouver
Sissoko C, Spitz S, Zhang Z, Abedi K, Kamm RD, Barrile R. Engineering the blood–brain barrier on chip: advances in preclinical drug penetration and disease modeling. Advanced Drug Delivery Reviews. 2026;234:115881. doi:10.1016/j.addr.2026.115881
BibTeX
@article{Sissoko2026,
author = {Sissoko, Cheick and Spitz, Sarah and Zhang, Zhengyu and Abedi, Kimia and Kamm, Roger D and Barrile, Riccardo},
title = {Engineering the blood–brain barrier on chip: advances in preclinical drug penetration and disease modeling},
journal = {Advanced Drug Delivery Reviews},
year = {2026},
volume = {234},
pages = {115881},
doi = {10.1016/j.addr.2026.115881}
}
EUVIMED